TANVEX BIOPHARMA, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39 TWD | +1.17% |
|
-1.39% | -40.09% |
| May. 28 | Tanvex BioPharma, Inc.(TWSE:6541) dropped from S&P Global BMI Index | CI |
| Mar. 14 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quotes 5-day view
End-of-day quote Taiwan S.E.| 2024-05-22 | 2024-05-23 | 2024-05-24 | 2024-05-27 | 2024-05-28 | |
|---|---|---|---|---|---|
| Last | 39 NT$ | 38.1 NT$ | 38 NT$ | 38.55 NT$ | 39 NT$ |
| Volume | 197 160 | 193 365 | 77 225 | 74 276 | 92 493 |
| Change | -1.39% | -2.31% | -0.26% | +1.45% | +1.17% |
| Opening | 38.15 | 39.55 | 38.10 | 38.50 | 38.60 |
| High | 40.60 | 39.55 | 38.45 | 39.00 | 39.70 |
| Low | 38.15 | 38.00 | 37.30 | 38.15 | 38.60 |
Performance
| 1 day | +1.17% | ||
| 1 week | -1.39% | ||
| Current month | -16.84% | ||
| 1 month | -18.75% | ||
| 3 months | -38.58% | ||
| 6 months | -45.30% | ||
| Current year | -40.09% | ||
| 1 year | -51.25% | ||
| 3 years | -79.35% | ||
| 5 years | -82.81% |
Volumes
marketsDaily volume
92 493
Avg. Volume 20 sessions
391 025
Avg. Volume 20 sessions TWD
15 249 975.00
Avg. Volume 20 sessions USD
471 696.98
Record volume 1
3 787 967
Record volume 2
3 152 645
Record volume 3
3 130 498
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (TWD)
198 678 421
Capitalization (USD)
198 678 421
Net sales ()
61
Number of employees
167
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
59.81 %
Free-Float capitalization (TWD)
118 837 313
Free-Float capitalization (USD)
118 837 313
Average Daily Capital Traded
7.68%
Highs and lows
1 week
37.30
39.70
1 month
35.0547.55
Current year
35.0566.50
1 year
35.0580.80
3 years
35.05245.22
5 years
35.05299.78
10 years
35.051 034.21
Indicators
Moving average 5 days
38.53
Moving average 20 days
41.72
Moving average 50 days
45.83
Moving average 100 days
54.10
Price spread / (MMA5)
-1.21%
Price spread / (MMA20)
+6.97%
Price spread / (MMA50)
+17.51%
Price spread / (MMA100)
+38.72%
STIM
RSI 9 days
37.53
RSI 14 days
35.09
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.17% | -1.39% | -40.09% | -51.25% | 199M | ||
| -2.20% | +1.10% | +9.83% | +35.42% | 115B | ||
| -1.20% | -2.09% | +10.80% | +34.22% | 105B | ||
| -2.94% | +2.20% | -10.84% | -10.61% | 22.71B | ||
| +4.12% | +3.05% | +2.36% | -6.34% | 21.83B | ||
| -0.28% | -6.01% | -10.37% | -29.66% | 18.18B | ||
| -0.38% | -3.32% | -41.92% | -35.99% | 16.52B | ||
| +0.26% | -8.53% | -15.11% | -35.37% | 16.01B | ||
| +0.77% | -0.05% | +6.62% | +54.00% | 14.14B | ||
| -8.21% | -12.23% | +17.53% | -10.64% | 10.71B | ||
| +0.65% | -2.98% | -30.73% | -33.98% | 7.6B | ||
| -0.80% | -1.84% | -3.30% | +22.75% | 7.47B | ||
| -0.09% | -6.72% | +9.39% | +40.29% | 7.47B | ||
| -2.36% | +3.65% | +1.10% | +41.87% | 7.3B | ||
| +4.16% | +1.76% | +251.21% | +206.71% | 7.21B | ||
| -2.73% | -13.22% | -61.42% | -72.81% | 6.25B | ||
| Average | -0.68% | -2.62% | +5.94% | +9.29% | ||
| Weighted average by Cap. | +0.01% | -1.32% | +6.43% | +20.29% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -40.09% | ||
| 2023 | -38.13% | ||
| 2022 | -39.59% | ||
| 2021 | +55.35% | ||
| 2020 | -16.42% | ||
| 2019 | -28.40% | ||
| 2018 | -35.50% | ||
| 2017 | -37.44% | ||
| 2016 | -35.73% | ||
| 2015 | +86.82% |
- Stock Market
- Equities
- 6541 Stock
- Quotes Tanvex BioPharma, Inc.
